| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.0M | +0.0% | — |
| R&D Expense | $488 | — | +0.0% |
| SG&A Expense | $702K | +18.0% | -8.7% |
| Operating Income | -$702K | -120.6% | +10.4% |
| Interest Expense | $4K | +141.3% | +20.9% |
| Pre-tax Income | -$609K | -117.3% | -106.8% |
| Net Income | -$609K | -117.3% | -106.8% |
| EPS (Basic) | -$0.06 | -117.1% | -104.2% |
| EPS (Diluted) | -$0.06 | -117.6% | -104.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $414K | -50.2% | -74.6% |
| Accounts Receivable | $4.0M | +0.1% | — |
| Current Assets | $5.5M | -9.7% | +71.7% |
| Total Assets | $12.6M | -4.6% | +131.1% |
| Current Liabilities | $782K | -5.4% | +32.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$979K | — | — |
| Financing Cash Flow | $82K | — | — |
| $2.5M |
| -3.8% |
| -0.1% |
| Stockholders' Equity | $10.2M | -4.8% | +240.2% |